Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Key RNA Markers Signal Pediatric Familial Hypercholesterolemia

March 13, 2026
Continue Reading
key-rna-markers-signal-pediatric-familial-hypercholesterolemia
Posted inBiotechnology

Hypusination of eIF5A Drives Aggressive Prostate Cancer

March 13, 2026
Continue Reading
hypusination-of-eif5a-drives-aggressive-prostate-cancer
Posted inBiotechnology

Boosting Self-Efficacy in Managing Breast Cancer Sequelae

March 13, 2026
Continue Reading
boosting-self-efficacy-in-managing-breast-cancer-sequelae
Posted inBiotechnology

SparStVR: Virtual Reality for Sparse 3D Histology

March 13, 2026
Continue Reading
sparstvr:-virtual-reality-for-sparse-3d-histology
Posted inBiotechnology

Unveiling the Glow: How Invisible Electric Fields Power Device Luminescence

March 13, 2026
Continue Reading
unveiling-the-glow:-how-invisible-electric-fields-power-device-luminescence
Posted inBiotechnology

New Model Predicts Preterm Infant Discharge Timing

March 13, 2026
Continue Reading
new-model-predicts-preterm-infant-discharge-timing
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

biomea’s-diabetes-drug-improves-glucose-control-3-months-after-fda-hold-lifted
Posted inBiotechnology

Biomea’s diabetes drug improves glucose control 3 months after FDA hold lifted

December 17, 2024
Three months after Biomea Fusion’s menin inhibitor was released from a clinical hold, the company has claimed a win in…
Read More
cash-strapped-portage-finds-hope-in-sale-of-lead-asset,-subsidiary-to-immunova
Posted inBiotechnology

Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova

December 17, 2024
After spending most of the year hunting for options to stay afloat, cash-strapped Portage Biotech appears to have found salvation…
Read More
fresh-off-$120m-raise,-ai-powered-terray-is-teaming-up-with-gilead-in-multi-pronged-r&d-pact
Posted inBiotechnology

Fresh off $120M raise, AI-powered Terray is teaming up with Gilead in multi-pronged R&D pact

December 17, 2024
Terray is ending the year on a high. Just two short months ago the biotech came out with a healthy…
Read More
fierce-biotech’s-top-10-editor’s-picks-for-2024
Posted inBiotechnology

Fierce Biotech’s top 10 editor’s picks for 2024

December 17, 2024
The year kicked off with a flurry of dealmaking at the J.P. Morgan Healthcare Conference in January, and the pace…
Read More
merck-drops-tigit-asset-and-lag-3-program,-discontinuing-several-phase-3-trials
Posted inBiotechnology

Merck drops TIGIT asset and LAG-3 program, discontinuing several phase 3 trials

December 16, 2024
Out with the old, in with the new. The end of the year in biopharma is typically marked by pipeline…
Read More
american-society-of-hematology-member-surveys-identify-barriers-to-improving-diversity-in-clinical-trials
Posted inResearch

American Society of Hematology member surveys identify barriers to improving diversity in clinical trials

December 16, 2024
A pair of assessments conducted by the American Society of Hematology (ASH) have helped identify roadblocks to improving diversity in…
Read More
boston-scientific-recalls-pacemakers-at-risk-of-triggering-permanent-safety-mode
Posted inMedical Technology

Boston Scientific recalls pacemakers at risk of triggering permanent safety mode

December 16, 2024
The FDA is boosting a recall effort from Boston Scientific regarding batteries potentially underpowering a number of the company’s implanted…
Read More
ucb’s-orchestra-hits-dud-note:-novartis-partnered-parkinson’s-asset-fails-phase-2
Posted inBiotechnology

UCB’s orchestra hits dud note: Novartis-partnered Parkinson’s asset fails phase 2

December 16, 2024
UCB’s Novartis-partnered investigational small molecule has failed to improve symptoms of Parkinson’s disease in a phase 2a trial. The oral…
Read More
roche-mothballs-another-hemophilia-a-gene-therapy-under-spark-amid-plans-to-debut-new-hematologic-asset
Posted inBiotechnology

Roche mothballs another hemophilia A gene therapy under Spark amid plans to debut new hematologic asset

December 16, 2024
Following the apparent elimination of a late-stage gene therapy study last week, Swiss drug juggernaut Roche has confirmed that it’s…
Read More
candid-therapeutics-unwraps-three-new-collaborations-to-discover-and-develop-t-cell-engager-antibodies
Posted inBiotechnology

Candid Therapeutics unwraps three new collaborations to discover and develop T-cell engager antibodies

December 16, 2024
Candid Therapeutics, a new San Diego biotech bent on becoming a leader in the emerging T-cell engager space, has unwrapped…
Read More

Posts pagination

Previous page 1 … 1,539 1,540 1,541 1,542 1,543 … 1,549 Next page
You May Have Missed
insulet,-abbott,-dexcom-set-sights-on-type-2-diabetes-at-attd
Posted inMedical Technology

Insulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTD

stryker-hit-by-international-cyberattack-linked-to-pro-iran-group
Posted inMedical Technology

Stryker hit by international cyberattack linked to pro-Iran group

bd-taps-sinteco-for-european-pharmacy-robotics-partnership
Posted inMedical Technology

BD taps Sinteco for European pharmacy robotics partnership

newly-minted-minimed-nets-eu-approval-for-780g-pump-and-abbott’s-instinct-cgm
Posted inMedical Technology

Newly minted MiniMed nets EU approval for 780G pump and Abbott’s Instinct CGM

Privacy Policy    Terms

Scroll to Top